Novo Nordisk Boardroom Coup: Ozempic Giant Shaken

Ozempic in Crisis? Novo Nordisk's board just imploded! The charity controlling the company seized power after a clash over the Ozempic maker's faltering performance, ousting the chairman and six directors. With shares tanking and competition fierce, can the new board save Novo Nordisk? Find out how this dramatic shakeup could impact the future of weight loss drugs.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.